Search by Drug Name or NDC

    NDC 68788-8137-02 Butalbital, Acetaminophen, Caffeine 325; 50; 40 mg/1; mg/1; mg/1 Details

    Butalbital, Acetaminophen, Caffeine 325; 50; 40 mg/1; mg/1; mg/1

    Butalbital, Acetaminophen, Caffeine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is ACETAMINOPHEN; BUTALBITAL; CAFFEINE.

    Product Information

    NDC 68788-8137
    Product ID 68788-8137_6beb0447-2292-4320-8e3f-b4fc79873abf
    Associated GPIs 64991003100310
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Butalbital, Acetaminophen, Caffeine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Butalbital, Acetaminophen, and Caffeine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 325; 50; 40
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; BUTALBITAL; CAFFEINE
    Labeler Name Preferred Pharmaceuticals Inc.
    Pharmaceutical Class Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
    DEA Schedule CIII
    Marketing Category ANDA
    Application Number ANDA209587
    Listing Certified Through 2024-12-31

    Package

    NDC 68788-8137-02 (68788813702)

    NDC Package Code 68788-8137-2
    Billing NDC 68788813702
    Package 20 TABLET in 1 BOTTLE (68788-8137-2)
    Marketing Start Date 2022-02-11
    NDC Exclude Flag N
    Pricing Information N/A